Does APREPITANT Cause Porphyria acute? 185 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Porphyria acute have been filed in association with APREPITANT (CINVANTI). This represents 3.3% of all adverse event reports for APREPITANT.
185
Reports of Porphyria acute with APREPITANT
3.3%
of all APREPITANT reports
166
Deaths
183
Hospitalizations
How Dangerous Is Porphyria acute From APREPITANT?
Of the 185 reports, 166 (89.7%) resulted in death, 183 (98.9%) required hospitalization, and 184 (99.5%) were considered life-threatening.
Is Porphyria acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Porphyria acute?
GIVOSIRAN (381)
RITUXIMAB (265)
DICLOFENAC (262)
LEFLUNOMIDE (249)
TOCILIZUMAB (243)
SECUKINUMAB (241)
METHOTREXATE (238)
ACETAMINOPHEN (237)
ADALIMUMAB (236)
PREDNISONE (227)
Which APREPITANT Alternatives Have Lower Porphyria acute Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL